NCT01176500View on ClinicalTrials.gov

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 28, 2010

Primary Completion Date

November 18, 2011

Study Completion Date

November 18, 2011

Conditions
Colon CancerLung CancerCervical CancerRenal Cell CarcinomaUterine Cancer
Interventions
DRUG

(18)Fluciclatide

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

National Institutes of Health Clinical Center (CC)

NIH

collaborator

GE Healthcare

INDUSTRY

lead

National Cancer Institute (NCI)

NIH